LONDON — Health authorities and patient advocates across the United Kingdom are pressing national health systems to overhaul how they respond to women’s medical concerns, arguing that decades of under-investment and persistent diagnostic delays have left millions of patients without timely or adequate care. The calls intensified this week following the publication of an independent review commissioned by the Department of Health and Social Care, which found that women wait an average of four years longer than men for diagnoses of conditions affecting both sexes equally.
The review, compiled over 18 months by a panel of clinicians, health economists, and patient representatives, examined more than 200,000 case files spanning ten conditions including autoimmune disorders, chronic pain syndromes, and cardiovascular disease. Researchers found that women presenting with heart attack symptoms were 40 percent more likely than male patients to be initially sent home without further investigation, and that referrals for specialist pain management took nearly twice as long on average for female patients.
“We have to respond to women’s health needs more easily,” said Dr. Constance Mallory, chair of the review panel and a professor of clinical epidemiology at Hartfield University. “The evidence is unambiguous. There is a structural bias embedded in our diagnostic protocols, our training curricula, and our resource allocation that we have to dismantle deliberately and quickly.” Dr. Mallory presented the findings at a parliamentary briefing on Tuesday and called for a dedicated women’s health fund to be established within the next budget cycle.
The review drew particular attention to conditions that disproportionately or exclusively affect women. Endometriosis, which affects an estimated one in ten women of reproductive age, carries an average diagnostic delay of eight years in the UK. Polycystic ovary syndrome, postnatal depression, and perimenopause-related illness were also flagged as areas where current pathways fall critically short. Patient groups testified that many women had been told their symptoms were psychological or stress-related before a physical cause was eventually identified.
Campaign groups welcomed the report but said they had heard similar promises before. “Every two or three years there is a review, and every review reaches the same conclusions,” said Harriet Osei-Bonsu, director of the advocacy group Women’s Health Matters. “What we need now is a binding implementation framework with ring-fenced funding and quarterly accountability reporting, not another set of recommendations that sits on a shelf.” Her organisation has been lobbying parliament for a statutory women’s health commissioner with powers to compel health trusts to meet minimum response time standards.
The government’s chief medical adviser acknowledged the review’s findings and said ministers were considering a formal response. A spokesperson for the Department of Health and Social Care said that an action plan would be published within 90 days, adding that several pilot schemes already underway in the north of England had shown measurable reductions in diagnostic wait times for women. Critics noted that those pilots covered fewer than 3 percent of the population and had not yet been evaluated for long-term outcomes.
International comparisons in the report showed that the UK’s performance, while below the European average for women’s health indicators, was not uniquely poor. Several peer nations face similar challenges, though Nordic countries were cited as models for integrated women’s health pathways that reduce duplication and improve follow-through. Sweden’s system of dedicated women’s health centres, funded through national block grants to regional authorities, was highlighted as a potential template.
The review also addressed structural factors that amplify inequity. Researchers found that women from lower-income backgrounds, Black and minority ethnic communities, and rural areas faced compounding disadvantages, experiencing even longer waits and higher rates of symptom dismissal than the overall female average. Rural women, in particular, were found to have significantly fewer options for specialist referral, with distances to women’s health centres averaging more than 40 miles in some regions of England and Wales.
Medical education emerged as a key pressure point. The review noted that many undergraduate medical curricula still devote fewer contact hours to women’s health topics than to conditions statistically more common in men, and that postgraduate training in areas such as endometriosis and pelvic pain remains largely optional. Professional bodies including several royal colleges have signalled support for mandatory curriculum reform, but implementation timelines remain uncertain.
Observers say the political momentum behind the issue is higher than it has been in a generation, partly driven by a broader public conversation about gender disparities in medicine and partly by an unusually well-organised coalition of patient groups, royal colleges, and academic researchers. The next significant milestone will be the government’s formal response to the review, expected later this summer, which advocates say will test whether the political will behind the rhetoric is real.